Publication | Closed Access

Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b–2, open-label study

Hematological MalignancyOncologyHealth-related QualityCiltacabtagene AutoleucelHematologyClinical TrialsPharmacotherapyCancer TreatmentMedicineRefractory Multiple MyelomaHealth Sciences